chlortalidone 50mg tablets
ennogen healthcare ltd - chlortalidone - oral tablet - 50mg
tenoretic 100/25mg tab tablet
astrazeneca canada inc - atenolol; chlorthalidone - tablet - 100mg; 25mg - atenolol 100mg; chlorthalidone 25mg - beta-adrenergic blocking agents
tenoretic 50/25mg tab tablet
astrazeneca canada inc - atenolol; chlorthalidone - tablet - 50mg; 25mg - atenolol 50mg; chlorthalidone 25mg - beta-adrenergic blocking agents
thalitone- chlorthalidone tablet thalitone- chlorthalidone tablet
casper pharma llc - chlorthalidone (unii: q0mqd1073q) (chlorthalidone - unii:q0mqd1073q) - thalitone® is indicated for the treatment of hypertension, to lower blood pressure. lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including the class to which this drug principally belongs. there are no controlled trials demonstrating risk reduction with thalitone. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than one drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such as those of the national high blood pressure education program’s joint national committee on prevention, detection, evaluation, and treatment of high b
chlortalidon hexal 25 mg tabletten
chlortalidon hexal 12,5 mg tabletten
chlortalidon hexal 50 mg tabletten
mivacron
pharmacy retailing (nz) ltd t/a healthcare logistics - mivacurium chloride 2.14 mg/ml equivalent to 2 mg/ml mivacurium cation - solution for injection - 2 mg/ml - active: mivacurium chloride 2.14 mg/ml equivalent to 2 mg/ml mivacurium cation excipient: hydrochloric acid water for injection - mivacron is a highly selective, short-acting, non-depolarising neuromuscular blocking agent with a fast recovery profile. mivacron is used as an adjunct to general anaesthesia to relax skeletal muscles and to facilitate tracheal intubation and mechanical ventilation.